Summary by Futu AI
Thomas H. Glocer, associated with Merck & Co., Inc., executed a transaction involving the company's common stock on May 31, 2024. The action involved a direct holding of shares, with the number of shares beneficially owned following the transaction totaling 5,100. The nature of the shares is direct, indicating personal ownership by Glocer. The transaction details, including the price and total value of the shares, were not disclosed in the announcement.